Publication:
Early Response to Everolimus Therapy Detected on Ga-68-DOTATATE PET/CT in a Patient with Pancreatic Neuroendocrine Tumor

Simple item page
dc.contributor.authorOzkan, Elgin
dc.contributor.authorSoydal, Cigdem
dc.contributor.authorSemirgin, Sibel Ucak
dc.contributor.authorYapici, Oktay
dc.contributor.authorAtmaca, Aysegul
dc.contributor.authorDemirag, Guzin
dc.contributor.authorIDOzkan, Elgin/0000-0001-8543-0744
dc.contributor.authorIDSoydal, Cigdem/0000-0002-6199-8551
dc.date.accessioned2020-06-21T13:32:50Z
dc.date.available2020-06-21T13:32:50Z
dc.date.issued2016
dc.departmentOMÜen_US
dc.department-temp[Ozkan, Elgin -- Soydal, Cigdem] Ankara Univ, Sch Med, Dept Nucl Med, TR-06100 Ankara, Turkey -- [Semirgin, Sibel Ucak -- Yapici, Oktay] Ondokuz Mayis Univ, Sch Med, Dept Nucl Med, Samsun, Turkey -- [Atmaca, Aysegul] Ondokuz Mayis Univ, Sch Med, Dept Endocrinol, Samsun, Turkey -- [Demirag, Guzin] Ondokuz Mayis Univ, Sch Med, Dept Med Oncol, Samsun, Turkey --en_US
dc.description.abstractEverolimus is a mammalian target of rapamycin inhibitor that has been recently approved for the treatment of patients with advanced progressive pancreatic neuroendocrine tumor. Here, we present a case in which an early therapy response to everolimus was effectively demonstrated by Ga-68-DOTATATE PET/CT.en_US
dc.identifier.doi10.1097/RLU.0000000000001242
dc.identifier.endpage563en_US
dc.identifier.issn0363-9762
dc.identifier.issn1536-0229
dc.identifier.issue7en_US
dc.identifier.pmid27163457
dc.identifier.startpage561en_US
dc.identifier.urihttps://doi.org/10.1097/RLU.0000000000001242
dc.identifier.urihttps://hdl.handle.net/20.500.12712/13275
dc.identifier.volume41en_US
dc.identifier.wosWOS:000377695800016
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.journalClinical Nuclear Medicineen_US
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectGa-68-DOTATATE PET/CTen_US
dc.subjectEverolimusen_US
dc.subjectTreatment Responseen_US
dc.titleEarly Response to Everolimus Therapy Detected on Ga-68-DOTATATE PET/CT in a Patient with Pancreatic Neuroendocrine Tumoren_US
dc.typeEditorialen_US
dspace.entity.typePublication

Files

Collections

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu